Literature DB >> 11130255

Initial experience of a nephrologist-operated vascular access center.

J W Jackson1, J L Lewis, J R Brouillette, R R Brantley.   

Abstract

A nephrology practice in Alabama did not feel in control of vascular access management. Scheduling delays, as well as variable techniques and outcomes, leading to high morbidity and mortality, caused frustration with the existing care system for vascular access. Our objective was to develop an integrative system of vascular access care, involving nephrologists along with the other caregivers, and to demonstrate an improvement in outcomes. Nephrology Vascular Labs (NVL), a recent RMS-Lifeline acquisition, opened a vascular access center (VAC) as an extension of the nephrology practice. Both pre-ESRD and ESRD patients are evaluated and treated in the VAC. Treatment is rendered in a timely fashion, to the benefit of the patients. Nephrologists serve as the interventionists. More than 90% of vascular access problems detected at dialysis are treated at the VAC. More than 2000 procedures have been performed over 2 years. Procedures carried out include thrombolysis with angioplasty, fluoroscopy alone or with angioplasty, placement of cuffed and noncuffed catheters, removal of cuffed catheters, and minor surgeries. Success rates have been high. Minor and major complications have been relatively low. Referrals to both surgeons and radiologists are shown to emphasize the role of the VAC as part of an integrative system of vascular access care. Results of a patient satisfaction survey were excellent. The VAC has fulfilled the vision of creating a seamless integration of care for vascular access. Hospitalization rate has been reduced and it is suspected that the global cost of access care is markedly lower than prior to the VAC. Multiple nephrologists can rotate as the VAC's interventionist and jointly obtain good outcomes and have little variability among them. Several reasons for using a nephrologists as the interventionist are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 11130255     DOI: 10.1046/j.1525-139x.2000.00099.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  2 in total

1.  Safety and efficacy of arteriovenous fistula angioplasties performed by nephrologists: report from a Brazilian interventional nephrology center.

Authors:  Ricardo P Franco; Miguel C Riella; Domingos C Chula; Marcia T de Alcântara; Marcelo M do Nascimento
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

2.  Comparison of treatment delay associated with tunneled hemodialysis catheter placement between interventionists.

Authors:  Yoo Hyung Kim; Hae Ri Kim; Hong Jae Jeon; Ye-Jin Kim; Sa Ra Jung; Dae Eun Choi; Kang Wook Lee; Ki Ryang Na
Journal:  Korean J Intern Med       Date:  2016-04-14       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.